News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilis Biotherapeutics Appoints Dr. Arthur Tzianabos To The Scientific Advisory Board


6/5/2014 7:49:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing best-in-class DNA-based therapeutics for rare genetic diseases, announced today that Arthur Tzianabos, Ph.D., has joined its Scientific Advisory Board. Dr. Tzianabos brings more than 20 years of experience in drug discovery and development of therapeutics in industry and academia. Dr. Tzianabos is currently Chief Scientific Officer of OvaScience, Inc., a global life sciences company developing new fertility treatments.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES